Atlas Trials

Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older

Clinical trial NCT06874842 · RECRUITING

Trial details

NCT number
NCT06874842
Sponsor
Guangzhou Patronus Biotech Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Herpes Zoster (HZ)
Start date
2025-03-13
Primary completion
2026-02-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.